SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2025

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1  

Results of Meeting

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Alterity Therapeutics Limited
     
  By: /s/ Geoffrey P. Kempler
    Geoffrey P. Kempler
    Chairman

 

Date: March 31, 2025

 

 

2

 

Exhibit 99.1

 

Disclosure of Proxy Votes
Alterity Therapeutics Limited
Extraordinary General Meeting
Monday, 31 March 2025

GPO Box 5193, Sydney, NSW 2001
P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world)
F +61 (0)2 8583 3040 E hello@automic.com.au
ABN 27 152 260 814

 

In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.

 

  Proxy Votes Poll Results (if
applicable)
Results
    Resolution   Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
FOR AGAINST ABSTAIN PROXY’S
DISCRETION
FOR AGAINST ABSTAIN OUTCOME
1 Ratification of prior issue of Shares P 782,564,458 657,057,386 83.96% 92,500,708 11.82% 1,534,571 33,006,364 4.22% 700,829,750 88.34% 92,500,708 11.66% 1,534,571 Carried
2 Ratification of prior issue of Shares P 467,191,617 341,671,945 73.13% 92,513,308 19.80% 1,654,571 33,006,364 7.06% 385,444,309 80.64% 92,513,308 19.36% 1,654,571 Carried
3 Approval for issue of Shares P 1,028,650,344 928,398,161 90.25% 66,938,959 6.51% 1,027,200 33,313,224 3.24% 972,477,385 93.56% 66,938,959 6.44% 1,027,200 Carried
4 Approval for issue of Options P 457,078,417 353,933,151 77.43% 69,832,042 15.28% 4,082,971 33,313,224 7.29% 398,012,375 85.07% 69,832,042 14.93% 4,082,971 Carried
5A Approval for issue of Securities – Placement – Peter Marks P 1,033,783,401 967,829,394 93.62% 36,790,262 3.56% 3,037,000 29,163,745 2.82% 1,007,759,139 96.48% 36,790,262 3.52% 3,037,000 Carried
5B Approval for issue of Securities – Placement – Brian Meltzer P 1,033,610,512 968,680,105 93.72% 35,766,662 3.46% 3,055,000 29,163,745 2.82% 1,008,609,850 96.58% 35,766,662 3.42% 3,055,000 Carried
5C Approval for issue of Securities – Placement – Lawrence Gozlan P 1,039,426,769 973,338,362 93.64% 36,924,662 3.55% 3,055,000 29,163,745 2.81% 1,013,268,107 96.48% 36,924,662 3.52% 3,055,000 Carried
6 Approval for issue of Options P 1,013,470,209 924,677,848 91.24% 49,802,116 4.91% 30,536,160 38,990,245 3.85% 974,434,093 95.14% 49,802,116 4.86% 30,536,160 Carried

 

 

 

 

  Proxy Votes Poll Results (if
applicable)
Results
Resolution Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
FOR AGAINST ABSTAIN PROXY’S
DISCRETION
FOR AGAINST ABSTAIN OUTCOME
7 Approval to refresh and amend 2004 ASX Plan P 1,039,321,019 908,349,072 87.40% 97,974,583 9.43% 4,684,750 32,997,364 3.17% 935,463,691 90.52% 97,974,583 9.48% 5,440,750 Carried
8 Approval to refresh and amend 2018 ADS Plan P 1,039,310,819 910,329,672 87.59% 95,983,783 9.24% 4,685,950 32,997,364 3.17% 938,200,291 90.72% 95,983,783 9.28% 4,685,950 Carried

 

 

 

 

 


Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025 Alterity Therapeutics 차트를 더 보려면 여기를 클릭.
Alterity Therapeutics (NASDAQ:ATHE)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025 Alterity Therapeutics 차트를 더 보려면 여기를 클릭.